Support PenkePictet Biopharmaceutical Mother
Portfolio
Holdings
| Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACAD.NASDAQ | ACADIA Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.384 | 0.818 | 639.3k | $2.2m | $11.9m |
| |||||||||||||
| ADPT.NASDAQ | Adaptive Biotechnologies Corp | USA | Healthcare | Biotechnology | 2024-09-30 | 1.182 | 0.392 | 1.7m | $2.6m | $13.9m |
| |||||||||||||
| AGIO.NASDAQ | Agios Pharm | USA | Healthcare | Biotechnology | 2024-09-30 | 0.866 | 1.088 | 494k | $13.7m | $17m |
| |||||||||||||
| ALKS.NASDAQ | Alkermes Plc | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-09-30 | 0.784 | 2.312 | 1.2m | $9.8m | $39.5m |
| |||||||||||||
| BBIO.NASDAQ | BridgeBio Pharma Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.313 | 0.923 | 544.5k | -$3.5m | $20.4m |
| |||||||||||||
| BLUE.NASDAQ | Bluebird bio Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.366 | 0.472 | 2.6m | $4.6m | $20.5m |
| |||||||||||||
| CHMA.NASDAQ | CHMA.NASDAQ | - | - | - | - | 0.93 | 0.271 | 588.1k | - | - | ||||||||||||||
| CHRS.NASDAQ | Coherus BioSciences Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.815 | 0.237 | 935.5k | -$714.7k | $1.1m |
| |||||||||||||
| CMRX.NASDAQ | Chimerix Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.909 | 0.278 | 805.1k | $1.2m | $3.1m |
| |||||||||||||
| EDIT.NASDAQ | Editas Medicine Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.337 | 0.512 | 1.1m | $2.3m | $1.5m |
| |||||||||||||
| ENTA.NASDAQ | Enanta Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.225 | 0.171 | 259.5k | $1.5m | $1.4m |
| |||||||||||||
| FGEN.NASDAQ | FibroGen Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.554 | 0.855 | 544.7k | -$1m | $277.2k |
| |||||||||||||
| FOLD.NASDAQ | Amicus Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.603 | 1.437 | 1.8m | $1m | $17.3m |
| |||||||||||||
| GRFS.NASDAQ | Grifols SA ADR | USA | Healthcare | Drug Manufacturers - General | 2024-09-30 | 0.26 | 0.864 | 1.7m | $21.7m | $12.9m |
| |||||||||||||
| ICPT.NASDAQ | ICPT.NASDAQ | - | - | - | - | 0.843 | 0.478 | 352.4k | - | - | ||||||||||||||
| IMUX.NASDAQ | Immunic Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 2.659 | 0.154 | 1.2m | $488.4k | $1.2m |
| |||||||||||||
| INCY.NASDAQ | Incyte Corporation | USA | Healthcare | Biotechnology | 2024-09-30 | 0.41 | 3.176 | 789.9k | $12.7m | $57.3m |
| |||||||||||||
| MDGL.NASDAQ | Madrigal Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.404 | 0.971 | 73.8k | $2.6m | $24.2m |
| |||||||||||||
| MYGN.NASDAQ | Myriad Genetics Inc | USA | Healthcare | Diagnostics & Research | 2024-09-30 | 0.654 | 0.869 | 595.2k | $4.7m | $7.6m |
| |||||||||||||
| NKTR.NASDAQ | Nektar Therapeutics | USA | Healthcare | Biotechnology | 2024-09-30 | 0.968 | 0.145 | 1.8m | $432k | $1.6m |
| |||||||||||||
| PTCT.NASDAQ | PTC Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.516 | 0.785 | 398.1k | -$5.4m | $18.4m |
| |||||||||||||
| QURE.NASDAQ | Uniqure NV | USA | Healthcare | Biotechnology | 2024-09-30 | 1.028 | 0.216 | 499.2k | $521.6k | $7.8m |
| |||||||||||||
| SNY.NASDAQ | Sanofi ADR | USA | Healthcare | Drug Manufacturers - General | 2024-09-30 | 0.045 | 4.262 | 1.1m | $35.2m | $59.4m |
| |||||||||||||
| SUPN.NASDAQ | Supernus Pharmaceuticals Inc | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-09-30 | 0.882 | 1.099 | 486.7k | $8.7m | $18.7m |
| |||||||||||||
| SYNH.NASDAQ | SYNH.NASDAQ | - | - | - | - | 0.24 | 0.841 | 249.1k | - | - | ||||||||||||||
| TBPH.NASDAQ | Theravance Biopharma Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 2.038 | 0.719 | 1m | $3.7m | $10.4m |
| |||||||||||||
| TVTX.NASDAQ | Travere Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.258 | 0.521 | 1m | -$383.2k | $22.2m |
| |||||||||||||
| VNDA.NASDAQ | Vanda Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.485 | 0.258 | 864.2k | $8m | $3.8m |
|
Trades
Buys
Report date: 2022-10-13
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| MDGL.NASDAQ | 73.8k | - | 5.1m | 59-82 | $328.14 | 451.8% |
| NKTR.NASDAQ | 846.4k | - | 3.3m | 3-5 | $0.89 | -70.1% |
Report date: 2021-04-13
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | Price Range | Price | % |
| CHMA.NASDAQ | 588.1k | - | 0.00 | 0-0 | - | - |
Adds
Report date: 2024-04-15
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ADPT.NASDAQ | 192.5k | 12.4 | 689.1k | 3-5 | $7.99 | 215.8% |
| AGIO.NASDAQ | 43.9k | 9.8 | 1.2m | 21-36 | $34.46 | 64.4% |
| EDIT.NASDAQ | 182.8k | 19.9 | 1.4m | 6-12 | $1.38 | -76.9% |
| FOLD.NASDAQ | 61k | 3.5 | 758.6k | 11-14 | $9.61 | -9.0% |
| SUPN.NASDAQ | 29.9k | 6.6 | 913.4k | 26-35 | $38.55 | 46.7% |
| TVTX.NASDAQ | 5.2k | 0.5 | 42.4k | 6-10 | $20.31 | 228.1% |
Report date: 2023-10-13
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ACAD.NASDAQ | 235k | 53.5 | 6.2m | 20-34 | $18.67 | -8.1% |
| ADPT.NASDAQ | 604.3k | 63.8 | 3.8m | 4-9 | $7.99 | 86.7% |
| ALKS.NASDAQ | 356.6k | 36.8 | 10.3m | 26-33 | $31.19 | 21.5% |
| BLUE.NASDAQ | 1m | 67.1 | 3.6m | 3-4 | $7.80 | 209.5% |
| CHRS.NASDAQ | 512.5k | 121.2 | 2.2m | 3-5 | $1.24 | -60.5% |
| EDIT.NASDAQ | 397.1k | 75.8 | 3.3m | 7-10 | $1.38 | -79.6% |
| ENTA.NASDAQ | 122.7k | 89.7 | 1.8m | 9-20 | $5.53 | -41.4% |
| GRFS.NASDAQ | 663.7k | 41.7 | 6.4m | 8-11 | $7.35 | -12.4% |
| MYGN.NASDAQ | 167.6k | 38.4 | 3m | 14-23 | $12.82 | -11.4% |
| QURE.NASDAQ | 179.5k | 56.2 | 1.5m | 6-11 | $15.67 | 163.4% |
| SNY.NASDAQ | 376.2k | 49.7 | 20.1m | 50-56 | $52.48 | 5.0% |
| SUPN.NASDAQ | 151.9k | 49.9 | 4.5m | 24-33 | $38.55 | 58.4% |
| TBPH.NASDAQ | 291.2k | 39.8 | 2.7m | 8-10 | $10.47 | 26.9% |
| TVTX.NASDAQ | 308.4k | 39.5 | 4m | 7-18 | $20.31 | 205.2% |
| VNDA.NASDAQ | 245.2k | 39.6 | 1.2m | 4-7 | $4.40 | 7.1% |
Report date: 2023-04-13
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ADPT.NASDAQ | 478.8k | 102.2 | 4.2m | 7-11 | $7.99 | 9.9% |
| ALKS.NASDAQ | 428.7k | 79.3 | 11.8m | 25-30 | $31.19 | 22.7% |
| BBIO.NASDAQ | 324k | 80.1 | 4.1m | 8-20 | $37.59 | 373.4% |
| BLUE.NASDAQ | 741.8k | 89.0 | 3.7m | 3-9 | $7.80 | 180.6% |
| EDIT.NASDAQ | 338k | 181.9 | 2.9m | 6-12 | $1.38 | -78.2% |
| ENTA.NASDAQ | 83.9k | 159.1 | 3.9m | 36-62 | $5.53 | -84.8% |
| FGEN.NASDAQ | 179.9k | 49.3 | 3.8m | 18-26 | $0.51 | -97.2% |
| GRFS.NASDAQ | 666.5k | 72.1 | 5.6m | 7-11 | $7.35 | 13.1% |
| ICPT.NASDAQ | 170.9k | 94.2 | 0.00 | 0-0 | - | - |
| IMUX.NASDAQ | 572.6k | 91.3 | 1m | 1-3 | $1.02 | -20.9% |
| MYGN.NASDAQ | 214.5k | 96.5 | 4.5m | 18-24 | $12.82 | -28.1% |
| NKTR.NASDAQ | 999.7k | 118.1 | 1.8m | 1-3 | $0.89 | 46.7% |
| QURE.NASDAQ | 105.2k | 49.1 | 2.1m | 18-23 | $15.67 | -13.0% |
| SYNH.NASDAQ | 125.2k | 101.1 | 0.00 | 0-0 | - | - |
| TBPH.NASDAQ | 354.7k | 94.0 | 3.7m | 9-12 | $10.47 | 13.2% |
| TVTX.NASDAQ | 359.8k | 85.4 | 7.6m | 18-23 | $20.31 | 14.0% |
| VNDA.NASDAQ | 280.4k | 82.9 | 1.9m | 6-8 | $4.40 | -27.3% |
Report date: 2022-10-13
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| BBIO.NASDAQ | 316.6k | 360.2 | 3.3m | 7-13 | $37.59 | 473.9% |
| BLUE.NASDAQ | 530.7k | 175.3 | 3.1m | 4-8 | $7.80 | 108.6% |
| CMRX.NASDAQ | 493.5k | 158.4 | 1m | 2-3 | $3.96 | 152.2% |
| GRFS.NASDAQ | 227.2k | 32.6 | 1.8m | 6-11 | $7.35 | 27.2% |
| ICPT.NASDAQ | 40.5k | 28.8 | 644.6k | 12-21 | - | - |
| IMUX.NASDAQ | 217.3k | 53.0 | 970k | 3-12 | $1.02 | -65.5% |
| QURE.NASDAQ | 99k | 85.9 | 2m | 17-26 | $15.67 | -6.4% |
| TBPH.NASDAQ | 193.5k | 105.2 | 1.8m | 8-11 | $10.47 | 39.0% |
| TVTX.NASDAQ | 112.3k | 36.4 | 2.8m | 22-29 | $20.31 | -7.2% |
Reduces
Report date: 2024-04-15
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ACAD.NASDAQ | -34.7k | -5.2 | -793.3k | 17-29 | $18.67 | 11.4% |
| ALKS.NASDAQ | -58.3k | -4.4 | -1.6m | 24-33 | $31.19 | 30.4% |
| GRFS.NASDAQ | -489.5k | -21.7 | -3.5m | 5-9 | $7.35 | 38.7% |
| INCY.NASDAQ | -36.2k | -4.4 | -2.1m | 53-63 | $72.59 | 35.9% |
| MYGN.NASDAQ | -9.2k | -1.5 | -200.9k | 19-24 | $12.82 | -32.4% |
| PTCT.NASDAQ | -9.1k | -2.3 | -255.9k | 24-33 | $46.45 | 97.0% |
| TBPH.NASDAQ | -21.2k | -2.1 | -193.6k | 8-10 | $10.47 | 27.5% |
Report date: 2023-10-13
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| BBIO.NASDAQ | -184.1k | -25.3 | -5.3m | 17-36 | $37.59 | 123.9% |
Comments
How you think about this?